{"id":"https://openalex.org/W7224614246","doi":"https://doi.org/10.1097/coc.0000000000001391","title":"Discovery of Promising USP21 Small Molecule Inhibitors","display_name":"Discovery of Promising USP21 Small Molecule Inhibitors","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224614246","doi":"https://doi.org/10.1097/coc.0000000000001391","pmid":"https://pubmed.ncbi.nlm.nih.gov/42956329"},"language":"en","primary_location":{"id":"doi:10.1097/coc.0000000000001391","doi":"https://doi.org/10.1097/coc.0000000000001391","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0000000000001391","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029455748","display_name":"Tarek Kanan","orcid":"https://orcid.org/0000-0003-1905-9558","observed_orcids":["https://orcid.org/0000-0003-1905-9558"]},"institutions":[{"id":"https://openalex.org/I1295876152","display_name":"Houston Methodist","ror":"https://ror.org/027zt9171","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1295876152"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarek Kanan","raw_affiliation_strings":["Division of Pulmonary, Critical Care and Sleep Medicine, Houston Methodist, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pulmonary, Critical Care and Sleep Medicine, Houston Methodist, TX","institution_ids":["https://openalex.org/I1295876152"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076727043","display_name":"Duaa Kanan","orcid":"https://orcid.org/0000-0003-1943-8371","observed_orcids":["https://orcid.org/0000-0003-1943-8371"]},"institutions":[{"id":"https://openalex.org/I2801980284","display_name":"University of Vermont Medical Center","ror":"https://ror.org/04cewr321","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801980284"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Duaa Kanan","raw_affiliation_strings":["Division of Hematology and Medical Oncology, University of Vermont Medical Center, VT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology and Medical Oncology, University of Vermont Medical Center, VT","institution_ids":["https://openalex.org/I2801980284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5042226156","display_name":"Manasa Kandula","orcid":"https://orcid.org/0000-0002-7616-3215","observed_orcids":["https://orcid.org/0000-0002-7616-3215"]},"institutions":[{"id":"https://openalex.org/I4210130227","display_name":"Peoria campus of the University of Illinois System","ror":"https://ror.org/02qrdc062","country_code":"US","type":"education","lineage":["https://openalex.org/I39422238","https://openalex.org/I4210130227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manasa Kandula","raw_affiliation_strings":["Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine, University of Illinois College of Medicine, Peoria, IL","institution_ids":["https://openalex.org/I4210130227"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.85757543,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11041","display_name":"Ubiquitin and proteasome pathways","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/usp21","display_name":"USP21","score":0.9879999756813049},{"id":"https://openalex.org/keywords/small-molecule-inhibitors","display_name":"small molecule inhibitors","score":0.8399999737739563},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9419999718666077},{"id":"https://openalex.org/keywords/pd-l1","display_name":"PD-L1","score":0.9769999980926514},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.8759999871253967},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.4909999966621399},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.7749999761581421},{"id":"https://openalex.org/keywords/mm-gbsa-binding-free-energy","display_name":"MM-GBSA binding free energy","score":0.8920000195503235},{"id":"https://openalex.org/keywords/deslorelin","display_name":"deslorelin","score":0.8330000042915344},{"id":"https://openalex.org/keywords/dotatate","display_name":"DOTATATE","score":0.9580000042915344},{"id":"https://openalex.org/keywords/vasopressin","display_name":"vasopressin","score":0.9710000157356262},{"id":"https://openalex.org/keywords/pentagastrin","display_name":"pentagastrin","score":0.9879999756813049},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":0.9160000085830688},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.5509999990463257}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7159000039100647},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.6840999722480774},{"id":"https://openalex.org/C103637391","wikidata":"https://www.wikidata.org/wiki/Q5308921","display_name":"Drug repositioning","level":3,"score":0.595300018787384},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.5942999720573425},{"id":"https://openalex.org/C519536355","wikidata":"https://www.wikidata.org/wiki/Q21021151","display_name":"Repurposing","level":2,"score":0.5512999892234802},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.51910001039505},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.501800000667572},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4943999946117401},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4399999976158142},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.41339999437332153},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.38839998841285706},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3330000042915344},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.3328000009059906},{"id":"https://openalex.org/C116569031","wikidata":"https://www.wikidata.org/wiki/Q899107","display_name":"Ligand (biochemistry)","level":3,"score":0.3127000033855438},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.2793999910354614},{"id":"https://openalex.org/C3019816032","wikidata":"https://www.wikidata.org/wiki/Q2575340","display_name":"Cancer treatment","level":3,"score":0.27889999747276306},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2750000059604645},{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.2671999931335449},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.2606000006198883},{"id":"https://openalex.org/C25602115","wikidata":"https://www.wikidata.org/wiki/Q407111","display_name":"Ubiquitin","level":3,"score":0.26030001044273376},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.25380000472068787},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.2508000135421753}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1097/coc.0000000000001391","doi":"https://doi.org/10.1097/coc.0000000000001391","is_oa":false,"landing_page_url":"https://doi.org/10.1097/coc.0000000000001391","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:42956329","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42956329","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":19,"referenced_works":["https://openalex.org/W1972758026","https://openalex.org/W1974389826","https://openalex.org/W1991794210","https://openalex.org/W2079092427","https://openalex.org/W2130479394","https://openalex.org/W2140247386","https://openalex.org/W2973457155","https://openalex.org/W2997718753","https://openalex.org/W2999327615","https://openalex.org/W3093039828","https://openalex.org/W3191464459","https://openalex.org/W4307450150","https://openalex.org/W4321367247","https://openalex.org/W4388440205","https://openalex.org/W4391542588","https://openalex.org/W4394934376","https://openalex.org/W4395011493","https://openalex.org/W4396615108","https://openalex.org/W4402630443"],"related_works":["https://openalex.org/W4410274772","https://openalex.org/W4404852691","https://openalex.org/W4366986883","https://openalex.org/W4410070338","https://openalex.org/W3093039828","https://openalex.org/W4415371187","https://openalex.org/W3005020703","https://openalex.org/W4412492439","https://openalex.org/W4395449575","https://openalex.org/W4402479536"],"abstract_inverted_index":{"OBJECTIVES:":[0],"Ubiquitin":[1],"specific":[2],"protease":[3],"21":[4],"(USP21)":[5],"is":[6,19,50,171],"considered":[7],"a":[8,51,78,106,172,182,191,216,230],"novel":[9,79,217],"lung":[10,25],"cancer":[11,26,185,222],"protein":[12],"target.":[13],"Research":[14],"has":[15,225],"revealed":[16],"that":[17,194],"USP21":[18,74,109,157],"highly":[20,52,88],"expressed":[21],"in":[22],"non-small":[23],"cell":[24],"and":[27,70,81,101,168,201,210,224],"its":[28],"inhibition":[29],"leads":[30],"to":[31,147,219],"decreased":[32],"levels":[33],"of":[34,72,96,150,181,184,228],"the":[35,46,68,73,148,154,179,204,226,235],"immune":[36],"checkpoint":[37],"inhibitor":[38],"programmed":[39],"death":[40],"ligand":[41],"1":[42],"(PD-L1).":[43],"Hence,":[44],"targeting":[45],"USP21/":[47],"PD-L-1":[48],"interaction":[49],"sought":[53],"after":[54],"therapeutic":[55],"strategy.":[56,86],"METHODS:":[57],"In":[58],"this":[59],"study,":[60],"we":[61],"applied":[62],"an":[63],"integrated":[64],"methodology":[65],"beginning":[66],"with":[67,105,134,239],"refinement":[69],"optimization":[71],"crystal":[75],"structure":[76,91],"via":[77],"computational":[80],"artificial":[82],"intelligence-":[83],"based":[84],"modeling":[85],"Our":[87,143,188],"predicted":[89],"chemical":[90],"was":[92],"used":[93,177,197],"for":[94,120,129,178,206,242],"screening":[95],"6877":[97],"molecules,":[98,122,132],"including":[99],"investigational":[100],"FDA-approved":[102],"drugs,":[103],"along":[104,133],"known":[107],"potent":[108],"inhibitor.":[110],"We":[111],"then":[112],"performed":[113],"10":[114],"ns":[115,126],"molecular":[116],"dynamics":[117],"(MD)":[118],"simulations":[119,128],"select":[121],"followed":[123],"by":[124,198],"100":[125],"MD":[127],"29":[130],"lead":[131],"post-MD":[135],"MM/GBSA":[136],"system":[137],"free":[138],"energy":[139],"\u0394G":[140],"calculations.":[141],"RESULTS:":[142],"comprehensive":[144],"analysis":[145],"led":[146],"discovery":[149,211],"7":[151],"molecules":[152],"as":[153],"most":[155],"promising":[156],"inhibitors.":[158],"These":[159],"drugs":[160],"are":[161],"deslorelin,":[162],"dotatate,":[163],"vedroprevir,":[164],"vasopressin,":[165],"pentagastrin,":[166],"furaprevir,":[167],"bleomycin,":[169],"which":[170],"currently":[173],"approved":[174],"anticancer":[175],"drug":[176,208],"treatment":[180],"variety":[183],"types.":[186],"CONCLUSIONS:":[187],"results":[189],"represent":[190],"strong":[192],"scaffold":[193],"can":[195],"be":[196],"scientists,":[199],"researchers,":[200],"chemists,":[202],"opening":[203],"route":[205],"further":[207],"design":[209],"research.":[212],"Drug":[213],"repurposing":[214],"offers":[215],"approach":[218],"identify":[220],"potential":[221,227],"therapeutics":[223],"making":[229],"significant":[231],"impact":[232],"on":[233],"reducing":[234],"financial":[236],"toxicity":[237],"associated":[238],"oncology":[240],"treatments":[241],"our":[243],"patients.":[244]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-10-30T00:00:00"}